Ronald Brus

Ronald Brus has a diverse work experience in the pharmaceutical and biotechnology industry. Ronald started their career as the Medical Director at Zambon B.V. in 1990 and later worked as a Product Planning Physician at Forest Laboratories from 1994 to 1996.

In 1997, Brus joined Crucell, a biotechnology company specializing in vaccines and biopharmaceutical technologies. Over the course of their time at Crucell, they held various roles including Executive Vice President of Business Development, Chief Business Officer, Chief Operating Officer, and CEO.

In 2010, Brus became a Member of the Executive Committee at Galapagos, a biotechnology company. Ronald later joined the healthcare technology companies myTomorrows.com and tested.me as the Founder and CEO and as a Co-founder, respectively.

Their most recent work experience includes co-founding Leyden Labs, a company dedicated to advancing accessible intranasal products for respiratory illnesses, and serving on the Board of Directors at Feyenoord Rotterdam N.V.

Throughout their career, Brus has focused on developing and licensing technologies related to vaccines, biopharmaceuticals, monoclonal antibodies, recombinant proteins, and gene therapy products. Ronald has demonstrated a commitment to improving patient access to innovative drug therapies and has contributed to the growth and success of the companies they have worked with.

Ronald Brus attended the University of Groningen from 1982 to 1989, where they obtained a Doctor of Medicine (MD) degree. No specific field of study information was provided.